loader

Roche reports solid sales growth in the first half of 2016

In the first semester of 2016, Roche Group recorded an increase of 4,8% in global sales, reaching out to 25 billion Swiss Francs, at a constant exchange rate.

Roche CEO Severin Schwan said: “The first half of this year, both Pharmaceutical and Diagnostic divisions had a good growth for sales, in all the regions where we operate. In this period we have successfully launched our first medicinal product of immunotherapy in oncology”.

 

For more information, please see the Romanian version of the article, here.

Authors

foto
ROCHE ROMANIA SRL